Trial intelligence / Profile preview

Intranasal Ketorolac for Pain After Dental Impaction Surgery

NCT01356225Phase 2Completed

Sponsor
Egalet
Start
Feb 2004
Primary completion
Mar 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in postoperative pain comparing Intranasal Ketorolac with Intranasal Placebo (2 arms). Primary endpoint: Summed Pain Intensity Difference at 8 hours. Started Feb 2004; status: completed.

02

Drugs

ketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01356225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01356225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call